Literature DB >> 8874624

Heat-mediated immune complex dissociation and enzyme-linked immunosorbent assay signal amplification render p24 antigen detection in plasma as sensitive as HIV-1 RNA detection by polymerase chain reaction.

J Schüpbach1, M Flepp, D Pontelli, Z Tomasik, R Lüthy, J Böni.   

Abstract

OBJECTIVE: To compare heat denaturation and acidification as immune complex dissociation (ICD) methods in adult HIV-1 infection and to increase the sensitivity by a signal-amplification-boosted HIV-1 p24 antigen enzyme-linked immunosorbent assay (ELISA).
DESIGN: Prospective and retrospective blinded study of paired serum and plasma samples from 245 patients (112 of class A, 66 of B, 67 of C of the Centers for Disease Control and Prevention 1993 classification).
METHODS: Plasma and sera were prospectively tested for antigen by ELISA using native, acidified, or heat-denatured material. Retrospective tests included batch analysis of heat-denatured samples for antigen by the signal-amplification-boosted ELISA and for viral RNA.
RESULTS: With serum, native antigen was reactive in 26.5%. Acidification increased the rate to 53.1% (P < or = 0.0001), but was inefficient at a CD4+ count > or = 500 x 10(6)/l. Heat denaturation further elevated the rate to 67.8% (P < or = 0.0007) and the use of plasma to 78.0% (P < or = 0.008). The boosted ELISA, performed with plasma samples diluted 1 :6, which eliminated the problem of heat-induced sample coagulation, was confirmed positive in 89.5% of serum and 97.8% of plasma samples. RNA was detected in 95.7%.
CONCLUSION: Heat-mediated ICD combined with a signal-amplification-boosted ELISA detects HIV-1 expression as sensitively as a polymerase chain reaction kit for viral RNA, but at only a fraction of the cost. The procedure uses a 50 microliters plasma sample and should be fully automatable.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8874624

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  30 in total

1.  Characterization of immune responses to capsid protein p24 of human immunodeficiency virus type 1 and implications for detection.

Authors:  Shixing Tang; Jiangqin Zhao; Aifeng Wang; Ragupathy Viswanath; Harri Harma; Richard F Little; Robert Yarchoan; Susan L Stramer; Phillipe N Nyambi; Sherwin Lee; Owen Wood; Eric Y Wong; Xue Wang; Indira K Hewlett
Journal:  Clin Vaccine Immunol       Date:  2010-06-09

2.  Potential of a simplified p24 assay for early diagnosis of infant human immunodeficiency virus type 1 infection in Haiti.

Authors:  Erik George; Carole Anne Beauharnais; Emilio Brignoli; Francine Noel; Gyrlande Bois; Patricia De Matteis Rouzier; Martine Altenor; Daniel Lauture; Marlène Hosty; Sapna Mehta; Peter F Wright; Jean W Pape
Journal:  J Clin Microbiol       Date:  2007-08-01       Impact factor: 5.948

3.  Evaluation of an ultrasensitive p24 antigen assay as a potential alternative to human immunodeficiency virus type 1 RNA viral load assay in resource-limited settings.

Authors:  Richard A Respess; Ada Cachafeiro; David Withum; Susan A Fiscus; Daniel Newman; Bernard Branson; Oliviero E Varnier; Kim Lewis; Timothy J Dondero
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

4.  Differences in humoral responses to the p24 antigen between Ethiopian and Swedish human immunodeficiency virus type 1-infected patients may suggest influences from a T-helper 2-like phenotype.

Authors:  T Kebede; S Britton; T Fehniger; A Vahlne; M Sällberg
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

5.  Detection and quantification of human immunodeficiency virus type 1 p24 antigen in dried whole blood and plasma on filter paper stored under various conditions.

Authors:  Chung-Chen Li; Kristy D Seidel; Robert W Coombs; Lisa M Frenkel
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

6.  p24 Antigen detection assay modified with a booster step for diagnosis and monitoring of human immunodeficiency virus type 1 infection.

Authors:  Ruengpung Sutthent; Narintorn Gaudart; Kulkanya Chokpaibulkit; Nattaya Tanliang; Chinda Kanoksinsombath; Pongsakdi Chaisilwatana
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

7.  Detection of acute HIV infection: a field evaluation of the determine® HIV-1/2 Ag/Ab combo test.

Authors:  Nora E Rosenberg; Gift Kamanga; Sam Phiri; Dominic Nsona; Audrey Pettifor; Sarah E Rutstein; Deborah Kamwendo; Irving F Hoffman; Maria Keating; Lillian B Brown; Beatrice Ndalama; Susan A Fiscus; Seth Congdon; Myron S Cohen; William C Miller
Journal:  J Infect Dis       Date:  2011-12-29       Impact factor: 5.226

8.  Diagnostic accuracy of ultrasensitive heat-denatured HIV-1 p24 antigen in non-B subtypes in Kampala, Uganda.

Authors:  L A Spacek; F Lutwama; H M Shihab; J Summerton; M R Kamya; A Ronald; O Laeyendecker; T C Quinn; H Mayanja-Kizza
Journal:  Int J STD AIDS       Date:  2011-06       Impact factor: 1.359

9.  Lack of longitudinal intrapatient correlation between p24 antigenemia and levels of human immunodeficiency virus (HIV) type 1 RNA in patients with chronic hiv infection during structured treatment interruptions.

Authors:  Julia G Prado; Ayumi Shintani; Margarita Bofill; Bonaventura Clotet; Lidia Ruiz; Javier Martinez-Picado
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

10.  Antigenemia in patients with mediterranean visceral leishmaniasis.

Authors:  Bernard Ferrua; Nicolas Rol; Grégory Michel; Pierre Marty
Journal:  J Clin Microbiol       Date:  2009-09-16       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.